Metformin as a new anti-cancer drug in adrenocortical carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin as a new anti-cancer drug in adrenocortical carcinoma

Published:2016-07-06 Issue:31 Volume:7 Page:49636-49648
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Poli Giada¹,Cantini Giulia¹,Armignacco Roberta¹,Fucci Rossella¹,Santi Raffaella²,Canu Letizia¹,Nesi Gabriella²,Mannelli Massimo¹,Luconi Michaela¹

Affiliation:

1. Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence Italy

2. Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes Mellitus in Non-Functioning Adrenal Incidentalomas: Analysis of the Mild Autonomous Cortisol Secretion (MACS) Impact on Glucose Profile;Biomedicines;2024-07-18

2. Anticarcinogenic Effects of Gold Nanoparticles and Metformin Against MCF-7 and A549 Cells;Biological Trace Element Research;2024-02-15

3. Adrenocortical Carcinoma;Biomedical Aspects of Solid Cancers;2024

4. Advances in translational research of the rare cancer type adrenocortical carcinoma;Nature Reviews Cancer;2023-10-19

5. Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System;Cancers;2023-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP